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Possible Role of the Phagocytic Proteinases, Cathepsin Β and 
Elastase, in Orthotopic Liver Transplantation 
H. Riess, M. Jochum, W. Machleidt, G. Himmelreich, R. Slama, and R. Steffen 
PREVIOUS studies have suggested that disseminated intravascular coagulation (DIC) is a causal factor for 
bleeding complications during orthotopic liver transplan­
tation (OLT). It seems likely that inflammatory mediators 
(eg, proteinases of phagocytes) in the perfusate released by 
the grafted liver may enter the circulation and induce the 
deterioration in hemostasis. The aims of our study were (1) 
to prove the presence of the cystein proteinase cathepsin Β 
from macrophages and the serine proteinase elastase from 
granulocytes in liver graft perfusate and (2) to evaluate the 
correlation of these proteinases with coagulopathy in OLT. 
MATERIALS AND METHODS 
Between August and November 1989, 10 consecutive patients 
undergoing primary O L T were studied. They received packed red 
blood cells (RBC) and fresh frozen plasma (FFP) , but neither 
platelets nor concentrates of coagulation factors. Eight blood 
samples were collected: (1) preoperatively, (2) 5 minutes before 
and (3) 10 minutes after removal of the liver, (4) 5 minutes before 
and (5) 5 minutes, (6) 15 minutes, (7) 1 hour, and (8) 12 hours after 
reperfusion of the liver graft. In addition, a sample of the perfusate 
was obtained after flushing of the graft with systemic blood. 
Antigen levels of D-dimer, thrombin-antithrombin Ill-complex 
(TAT) , von Willebrand factor (vWF), and elastase (in complex 
with alpha I-protease inhibitor, E P I ) , as well as activities of 
fibrinogen, protein C, änlithroffibifl III (AT III), CrinhibitGT, and 
cathepsin Β were determined. Wilcoxon's rank-sum test was used 
to analyze the data. Ρ values < .05 were considered to be 
significant. 
RESULTS 
Levels of νWF and fibrinogen were lower in the perfusate 
samples than in the corresponding plasma specimen, col­
lected 5 minutes before reperfusion of the graft (Table 1). 
Table 1. Coagulation Profiles of Venous Blood (5 minutes 
Before Reperfusion) and Perfusate 
Before Reperfusion Perfusate 
Mean Range Mean Range 
vWF (%) 317 94^05 275 3G-446 
Fibrinogen (g/L) 1.9 1.1-2.7 1.5* 0.5-2.2 
AT III (%) 66 35-89 38* 26-56 
(^-inhibitor (%) 78 55-107 64* 27-92 
Protein C (%) 27 8-54 10* 0-24 
TAT (ng/mL) 59 15-270 121* 10-324 
D-dimer (mg/L) 1.7 0-4.0 3.3 0-16.0 
EPI (ng/mL) 452 231-766 553 136-904 
Cathepsin Β (U/mL) 0.2 0.1-0.2 27.6* 7.0-75.8 
*P < .05 compared with the value of venous blood sample. 
mU/ l (cath .B) , ng/ml (EPI ) (TAT) ng/ml 
1 2 3 4 5 6 7 8 
1 - 8: number of s a m p l e , ^ r e p e r f u s i o n 
Fig 1. Concentrations of cathepsin B, thrombin-antithrombin 
complex (TAT), and elastase alpha 1-protease inhibitor complex 
(EPI) during orthotopic liver transplantation. 
These differences, however, were significant only for 
fibrinogen. In addition, the activities of AT I I I , protein C, 
and C,-inhibitor were significantly reduced in the perfus­
ate. On the other hand, levels of TAT and D-dimer 
(indicating activated coagulation), as well as EPI and 
cathepsin Β (indicators of activated phagocytes) in the 
perfusate, were significantly increased (Table 1). Plasma 
levels of cathepsin Β remained unchanged until the reper­
fusion phase. At that time a significant increase in the 
extracellularly released phagocytic proteinase cathepsin Β 
was evident. EPI plasma levels increased steadily for up to 
60 minutes after reperfusion. At the end of the observation 
period the plasma concentrations of both phagocytic en­
zymes—especially of EPI—were significantly greater than 
the preoperative levels (Fig 1). TAT level slowly increased 
during the anhepatic phase but showed a highly significant 
increase, reaching its maximal level 15 to 60 minutes after 
reperfusion followed by a decrease to the preoperative 
level 12 hours after reperfusion (Fig 1). 
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DISCUSSION 
Flushing of the liver graft removes most, but not all, of the 
preservation fluid. This is demonstrated by the decreased 
levels of coagulation proteins in the perfusate compared 
with those in the systemic circulation. On the other hand, 
significantly elevated levels of phagocytic proteinases, 
well known as potent inflammatory mediators, were found 
in the perfusate, and they may enter the systemic circula­
tion. Cathepsin Β is an effective lysosomal cysteine pro­
teinase of broad specificity, without an adequate inhibitory 
potential in plasma.1 The release of cathepsin Β from the 
liver macrophages, reflected by the excessive elevation in 
the perfusate, results in a steep and sustained increase in 
cathepsin Β activity in plasma. Therefore, cathepsin Β 
may play an important role in the activation and consump­
tion of plasma factors and may be responsible for the 
decompensation of preexisting low-grade DIC. Elastase, a 
lysosomal proteinase from granulocytes,2 may be released 
from such cells still sticking in the liver graft vessels. On 
the other hand, the protracted increase in EPI may reflect 
an ongoing inflammation response of leukocytes entering 
the operative field and liver graft. Activation of the coag­
ulation system, demonstrated by the highly significant 
increases in TAT (Fig 1) and fibrin monomers and D-dimer 
(not shown), as well as the pronounced decrease in the 
activities of the coagulation inhibitors, is consistent with 
the hypothesis that the coagulation system becomes fur­
ther activated by mediators released from the liver graft. 
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